Heron Therapeutics Announces Q2 2025 Financial Results and Highlights Commercial Progress
Provided By PR Newswire
Last update: Aug 8, 2025
CARY, N.C., Aug. 8, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three and six months ended June 30, 2025 and recent corporate updates.
Read more at prnewswire.com
